GALERA THERAPEUTICS, INC. (GRTX) Social Stream
GALERA THERAPEUTICS INC (GRTX) Price Targets From Analysts
Use the tables below to see what analysts covering GALERA THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-12 | 3 | $2 | $2 | $2 | $0.139 | 1338.85% |
| 2021-12-14 | 3 | $2 | $2 | $2 | $0.139 | 1338.85% |
| 2021-12-15 | 3 | $15 | $4 | $9.666 | $0.139 | 6853.96% |
| 2022-05-19 | 4 | $20 | $4 | $12.25 | $0.139 | 8712.95% |
| 2022-12-13 | 3 | $10 | $2 | $6 | $0.139 | 4216.55% |
| 2023-02-15 | 2 | $10 | $2 | $6 | $0.139 | 4216.55% |
| 2023-02-16 | 2 | $10 | $7 | $8.5 | $0.139 | 6015.11% |
| 2023-03-10 | 3 | $10 | $6 | $7.666 | $0.139 | 5415.11% |
| 2023-07-17 | 3 | $7 | $6 | $6.333 | $0.139 | 4456.12% |
| 2023-08-10 | 3 | $7 | $0.5 | $4.5 | $0.139 | 3137.41% |
| 2023-08-11 | 4 | $6 | $0.5 | $2.333 | $0.139 | 1578.42% |
| 2023-08-16 | 4 | $0.5 | $0.3 | $0.433 | $0.139 | 211.51% |
| 2023-08-29 | 3 | $0.5 | $0.25 | $0.416 | $0.139 | 199.28% |
| NA | 3 | $NA | $NA | $NA | $0.139 | NA% |
The Trend in the Analyst Price Target
GRTX's average price target has moved down $11.33 over the prior 43 weeks.
GRTX reports an average of 323.06% for its upside potential over the past 37 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-12-13 | 3 | 20.0 | 2.00 | 10.666 | 1.720 | 520.12% |
| 2022-12-13 | 2 | 10.0 | 2.00 | 6.000 | 1.720 | 248.84% |
| 2022-12-13 | 2 | 20.0 | 2.00 | 11.750 | 1.720 | 583.14% |
| 2023-05-11 | 3 | 7.0 | 6.00 | 6.333 | 3.110 | 103.63% |
| 2023-08-29 | 3 | 0.5 | 0.25 | 0.387 | 0.209 | 85.17% |
GRTX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3.25 | 0 | 0 | 3 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
Over the past 20 months, GRTX's average broker recommendation rating worsened by 1.66.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- GRTX has a higher upside potential (average analyst target price relative to current price) than 1747.39% of all US stocks.
- In the context of all US stocks, GALERA THERAPEUTICS INC's average analyst price target is higher than 118.33% of them.
- GRTX has a higher number of analysts covering the stock than 176.04% of all US stocks.
- To contextualize these metrics, consider that out of stocks in the small market cap category, GALERA THERAPEUTICS INC's variance in analysts' estimates is lower than -1194.96% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to GALERA THERAPEUTICS INC are RAPT, PHAT, and TFFP.
View All Top Stocks by Price Target
Is GRTX a Buy, Hold or Sell? See the POWR Ratings now!